A dose-finding Phase I study of F8IL10 intra-articular treatment in Rheumatoid Arthritis

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517896-19-00

Acronym

PH-F8IL10INTRA-03/24

Enrollment

Registered

2025-04-22

Start date

2025-09-29

Completion date

Unknown

Last updated

2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ankle, biologic and/or targeted synthetic), conventional, despite treatment with stable doses (for at least 3 months) of disease-modifying antirheumatic drugs (DMARDs, Patients with Rheumatoid Arthritis (RA) who, present arthritis flare(s) suitable for intra-articular (IA) injection in a knee, shoulder, wrist or elbow.

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Italy

Outcome results